Allard, Sabine D <br/><br/>
A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption.  [electronic resource] 

 -  Clinical immunology (Orlando, Fla.)  Mar 2012 
 - 252-68 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-7035 
<br/><br/><label>Standard No.: </label>10.1016/j.clim.2011.10.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--immunology<br/>Adult<br/>Aged<br/>Cells, Cultured<br/>Dendritic Cells--immunology<br/>Gene Products, rev--immunology<br/>Gene Products, tat--immunology<br/>HIV Infections--immunology<br/>HIV-1--immunology<br/>Humans<br/>Immunization<br/>Male<br/>Middle Aged<br/>nef Gene Products, Human Immunodeficiency Virus--immunology